Australia's contribution to the global COVAX initiative helps secure future vaccines. Here's the full field of candidates.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
Will a vaccine for COVID-19 be safe? Animal testing, human clinical trials and post-approval surveillance give us good grounds to believe that a future approved vaccine will work and be safe.
From adenoviruses to RNA: the pros and cons of different COVID vaccine technologies
A tragic error showed how complicated it can be to distribute vaccines on a mass scale.
Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.
Clear messages from experts helped New Zealand to contain COVID-19 outbreaks. The same is now necessary to counter vaccine misinformation and to build public trust in vaccination.
The vaccines being tested in South Africa have been included on the World Health Organization’s list of 26 most viable candidate vaccines to enter human clinical trials.
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Church leaders have raised concerns over a COVID-19 vaccine produced using cells derived from aborted foetuses. But the Vatican has already ruled such vaccines 'morally separate' from the abortions.
Those opposing vaccinations often mistrust government, science and the news media. There may be better ways to persuade them than by offering facts only.
The vaccine hasn't completed phase 3 trials, so we can't be sure it will be safe and effective for all. The Australian government's deal is contingent on these trials being successful.
As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
Most people will know someone who has succumbed to conspiracy theories about coronavirus – here's how to talk to them.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.
Nanoparticles dressed up in cell membranes snag SARS-CoV-2 virus particles before they reach human cells.
South Africa is trialling a vaccine for COVID-19. Here's what you need to know about it.
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.